Status: Recruiting
A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1
The purpose of this clinical study is to compare and evaluate the pharmacokinetic characteristics and the safety between administration of BR2021 and BR2021-1 in patients with metastatic adenocarcinoma of the pancreas
Participants needed: 20
Trial details
Phase: Phase 1Age: 19-74Biological sex: AllType: InterventionalSponsor: Boryung Pharmaceutical Co., LtdUpdated: Apr 10, 2025Locations: 2
Eligibility criteria
Those with histologically or cytologically proven metastatic adenocarcinoma of t... [+2]
In the case of a female subject, pregnant woman or those suspected pregnancy or... [+4]